Tag: mllstart!

Swiss Venture Capital Report 2026

startupticker.ch | February 2026

MLLStart! Barbecue-Party | 29 August 2024

Can you think of a better way to end a summer day than with a cool drink in your hand and the scent of barbecue in your nose above the rooftops of Zurich?

Firm News

Event | MLLStart! | AI Sparx: Healthcare | 8 February 2024 | TrustSquare | Zurich

In collaboration with TrustSquare, Microsoft and EY MLLStart! invites you to the event “AI Sparx: Healthcare” on 8 February 2024, Bellerivestrasse 201, Zurich.

Firm News

MLLStart! acts as Swiss Lead Counsel in the acquisition of TrainAway by boddy

With the recent acquisition of the Danish company TrainAway by Swiss travel-tech start-up company boddy, the world’s largest wellbeing network for travellers has been created. It has been a pleasure advising boddy in our capacity as Swiss Lead Counsel on the successful acquisition of 100% of TrainAway’s shares.

Firm News

Start-up Stories Night Event: 31 August 2022, Zurich

MLLStart!’s Start-up Stories Night event will take place on Wednesday 31 August 2022 in Zurich. The Start-up Stories Night event series provide a platform to discuss important topics for start-ups and investors.

Firm News

MLLStart! Barbecue-Party | 18 August 2022

Join us for our MLLStart! Barbecue-Party on Thursday, 18 August 2022, 6.30 pm on our rooftop terrace in the beautiful Kreis 5.

Firm News

MLLStart! advised Clinical Research Ventures (CR Ventures) in its investment into BioVersys AG in a Series C financing round

Start-up desk MLLStart! advised Clinical Research Ventures (CR Ventures), a global life-science investor with a focus on companies entering Phase I or II clinical trials based in Boston, USA, in its investment in a Series C financing round of BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies…

Firm News

Start-up Stories Night Event: 23 March 2022, Zurich

MLLStart!’s Start-up Stories Night event will take place on Wednesday 23 March 2022 in Zurich. The Start-up Stories Night event series provide a platform to discuss important topics for start-ups and investors.

Firm News

MLLStart! advised Clinical Research Ventures (CR Ventures) in its investment into BioVersys AG

MLLStart! advised Clinical Research Ventures (CR Ventures), a Singapore, Frankfurt and Boston based global life-science investor with a focus on companies entering Phase I or II clinical trials in its investment into BioVersys AG, Basel, a biotech company focusing on research and development of small molecules which switch off drug resistance against antibiotics.

Special Desk

MLLStart!

Do you have a brilliant business idea you want to conquer the market with? Do you want to grow your business and expand into new markets? The MLLStart!-team is familiar with the legal challenges startups face at all stages of their development. We can advise you on all the legal challenges you might find on…